Last reviewed · How we verify
NCT02154009
Clinical Autonomic Disorders: A Training Protocol
trial in Posttraumatic Stress Disorder in 21 participants. Terminated before completion.
15 August 2019
Quick facts
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS) |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 21 |
| Start date | 5 June 2014 |
| Primary completion | 15 August 2019 |
| Estimated completion | 7 April 2021 |
| Sites | 1 location across United States |
Conditions studied
- Posttraumatic Stress Disorder — all drugs for Posttraumatic Stress Disorder →
- Pseudopheochromocytoma — all drugs for Pseudopheochromocytoma →
- Healthy Volunteers — all drugs for Healthy Volunteers →
- Neurocardiogenic Syncope — all drugs for Neurocardiogenic Syncope →
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Who can join
2 and older, any sex, with Posttraumatic Stress Disorder or Pseudopheochromocytoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: \- The autonomic nervous system helps control things that happen automatically in the body, like blood pressure, heart rate, and digestion. When it doesn t work properly, it s called dysautonomia. Researchers want to learn more about dysautonomias and train doctors to learn how to better diagnose them. Objectives: * To allow people with autonomic disorders to be evaluated. * To help fellows in the NIH Autonomic Disorders fellowship program see a variety of diseases in their training. Eligibility: * People age 18 and older with dysautonomia; children over age 2 if they might benefit * Healthy adult volunteers Design: * Participants will have different procedures depending on their symptoms. They will have one or more visits. They will have some but not all of the tests below. * Participants will have a medical history and physical exam. They may be tested for problems thinking. They may complete a symptom questionnaire. They may have their temperature and blood pressure taken. * Participants may have an intravenous line placed. A needle will guide a thin plastic tube into an arm vein. * Participants may have blood drawn several times. They may give a urine sample. * Participants may have an electrocardiogram. * How much blood a participant s heart is pumping and/or how much blood is flowing through their arm may be measured. The total amount of blood in their bloodstream may be measured. * Participants may have their ability to sweat and/or sense of smell tested. * Breathing, bowel sounds, and/or body functions may be monitored. * Pupil size, response to environmental temperature changes, and/or breathing may be measured. * Participants may have a bladder ultrasound. * Small pieces of skin may be taken for study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02154009
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Posttraumatic Stress Disorder
Currently open trials in the same condition.
- NCT04529031 — Biomolecular Characteristics of Reminder-Focused Positive-Psychiatry · NA · recruiting
- NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
- NCT07176273 — Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD) · NA · recruiting
- NCT07105345 — Exploring Efficacy of Multi-Mode Cognitive Processing Therapy (CPT) for PTSD · NA · recruiting
- NCT06608277 — Ketamine, SGB and Combination Treatment for TBI · Phase 2 · recruiting
Other National Institute of Neurological Disorders and Stroke (NINDS) trials
Trials by the same sponsor.
- NCT07137442 — Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques · recruiting
- NCT02522611 — Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain · Phase 1, PHASE2 · not yet recruiting
- NCT07511049 — Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study · Phase 2 · not yet recruiting
- NCT07416188 — Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma · Phase 1, PHASE2 · not yet recruiting
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02154009 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute of Neurological Disorders and Stroke (NINDS)
- Last refreshed: 8 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02154009.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing